Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01508689 · ClinicalTrials.gov registry record · NA
Effect of Calcium-fortified Cereal Bars on Dietary Calcium Intake in Women
A NA study, sponsored by Texas Woman's University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01508689: Completed NA study, sponsored by Texas Woman's University.
NCT01508689 is a NA study that has completed, run by Texas Woman's University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01508689, a NA study, has completed, sponsored by Texas Woman's University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether eating Kellogg's Nutri-Grain cereal bars will increase calcium intake in healthy adult women.
Primary Outcome
1 form of 3-day diet diary per week will be assessed during weeks 2, 6, and 8 of study
Interventions
- BEHAVIORAL Receive Kellogg's Nutri-Grain® cereal bars first
- BEHAVIORAL Receive Kellogg's Nutri-Grain® cereal bars second
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01508689 record still lists
NCT01508689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Receive Kellogg's Nutri-Grain® cereal bars first is the first listed.
NCT01508689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01508689 about?
NCT01508689 is a clinical study titled "Effect of Calcium-fortified Cereal Bars on Dietary Calcium Intake in Women". The purpose of this study is to determine whether eating Kellogg's Nutri-Grain cereal bars will increase calcium intake in healthy adult women.
What is the current status of trial NCT01508689?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01508689?
The interventions under investigation include: Receive Kellogg's Nutri-Grain® cereal bars first (BEHAVIORAL), Receive Kellogg's Nutri-Grain® cereal bars second (BEHAVIORAL).
Who is sponsoring clinical trial NCT01508689?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01508689's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia